Pygeum Africanum for Anti-Inflammatory

Research suggests that Pygeum africanum extract possesses meaningful anti-inflammatory properties, with in vitro and animal studies pointing to several plausible mechanisms, including inhibition of the 5-lipoxygenase pathway to reduce leukotriene production, suppression of pro-inflammatory cytokines such as IL-6, TNF-α, and IL-27, and reduction of neutrophil recruitment in lung inflammation models. Studies indicate these effects may be relevant to conditions like benign prostatic hyperplasia, where inflammation is considered a contributing factor, though the available evidence consists primarily of laboratory and animal studies rather than controlled human clinical trials. Broader reviews of nutraceuticals for prostate health acknowledge Pygeum's presence in the literature but generally characterize its evidence base as preliminary compared to more extensively studied compounds. As such, while the directional findings are largely supportive, the absence of robust human trial data means the clinical significance of these anti-inflammatory effects remains to be fully established.